Stock info Insulet Corp | Filter  Basic-Info

Insulet Corp

The core activities of Insulet Corp are in the health care eq. & services sector. The past 10 years the (international) industry gained at around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.

The past year was a profitable year for Insulet Corp investors

Over the past year the company' stock gained around 4 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 116 percent. Insulet Corp's revenues between 2011 and 2015 were quite unstable and moved between 211,37 million dollars and 324,23 million dollars. The net results between 2011 and 2015 were far from constant and fluctuated between -45,83 million dollars and -73,52 million dollars.

Insulet Corp didn't pay out any dividends (in the past 5 years).

Insulet Corp financed with a quite low debt position

At the end of 2015 the health care company's balance sheet was worth 275,13 million dollars. Of the total balance sheet 241,08 million dollars (87,62 percent) was financed by debt. At the end of 2015 the health care company's stock was traded with a price/earnings-ratio -36. So the stock' value was -36 times the 2015' earnings per share. Based on the classical stock valuation theories the American stock can be seen as a growth stock.

The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 2,08 billion dollars. At the end of 2015 the American company had around 56,79 million stocks listed.

All Insulet Corp's annual reports can be found here. More information about Insulet Corp can be found it's website. .